Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 - Bonaventura, Aldo; Vecchié, Alessandra; Dagna, Lorenzo; Martinod, Kimberly; Dixon, Dave L.; Van Tassell, Benjamin W.; Dentali, Francesco; Montecucco, Fabrizio; Massberg, Steffen; Levi, Marcel; Abbate, Antonio (Nature reviews. Immunology, 2021)
Keywords: 631/250/127; 631/250/2499; 631/250/2500; 631/250/255/2514; 631/250/262; Biomedical and Life Sciences; Biomedicine; Blood clot; Blood Coagulation - immunology; Blood Platelets - immunology; Coronaviruses; COVID-19; COVID-19 - immunology; COVID-19 - pathology; Critical Illness - therapy; Cytokine Release Syndrome - immunology; Cytokine Release Syndrome - pathology; Development and progression; Drug development; Endothelium; Endothelium, Vascular - pathology; Fibrinolytic Agents - therapeutic use; Health aspects; Humans; Immune response; Immune system; Immunity, Innate - immunology; Immunology; Immunosuppressive agents; Infections; Leukocytes (neutrophilic); Lung - blood supply; Lung - pathology; Lung - virology; Monocytes; Monocytes - immunology; Neutrophils - immunology; Patients; Perspective; Respiratory distress syndrome; SARS-CoV-2 - immunology; SARS-CoV-2 - pathogenicity; Severe acute respiratory syndrome coronavirus 2; Thrombosis; Venous Thrombosis - immunology; Venous Thrombosis - pathology; Venous Thrombosis - prevention & control; United States